title: Inhibition of benzo[a]pyrene- and cyclophoshamide-induced mutagenicity by Cinnamomum cassia.
abstract: Cinnamomum cassia is used as a flavoring spice with some established medicinal properties. In this study, we evaluated the antimutagenic effect of C. cassia against two mutagens, viz. benzo[a]pyrene (B[a]P) and cyclophosphamide (CP). The antimutagenic properties of C. cassia were examined by the Ames test. In vivo chromosomal aberration (CA) and micronuclei tests were also employed to assess the antimutagenic effect of C. cassia in mice after pretreatment with the extract orally for seven consecutive days. To elucidate the mechanism by which C. cassia exerts its antimutagenic effect, certain key enzymes involved in bioactivation and detoxification processes were also investigated. Changes in liver cytochrome P450 (Cyt P450), glutathione content (GSH), glutathione S-transferase (GST), glutathione reductase (GR), and glutathione peroxidase (GPX) were evaluated in pretreated animals. It was observed in the Ames test, bone marrow chromosomal aberration assay, and micronucleus test that C. cassia exerted significant antimutagenic effects against B[a]P and CP in animals treated with the plant extract. C. cassia pretreatment decreased Cyt P450 content but increased GSH content and the activity of glutathione-dependent antioxidant enzymes, viz. GST, GR, and GPX. The present findings demonstrate that the antimutagenic potential of C. cassia could be attributed to its modulatory effect on the xenobiotic bioactivation and detoxification processes.
authors.affiliation: Department of Medical Elementology and Toxicology, Jamia Hamdard, Hamdard University, New Delhi 110062, India.
authors.forename: N
authors.initials: N
authors.lastname: Sharma
authors.forename: P
authors.initials: P
authors.lastname: Trikha
authors.forename: M
authors.initials: M
authors.lastname: Athar
authors.forename: S
authors.initials: S
authors.lastname: Raisuddin
mesh_terms: D000284:Administration, Oral; D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D001564:Benzo(a)pyrene; D002273:Carcinogens; D002869:Chromosome Aberrations / Q000139:chemically induced / Q000517:prevention & control*; D025063:Chromosome Disorders; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000378:metabolism; D019770:Lauraceae / Q000737:chemistry; D008297:Male; D051379:Mice; D015162:Micronucleus Tests; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009152:Mutagenicity Tests; D010088:Oxidoreductases / Q000187:drug effects*; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012486:Salmonella typhimurium / Q000187:drug effects; D017365:Spices
chemical_list: D016587:Antimutagenic Agents; D002273:Carcinogens; D010936:Plant Extracts; D001564:Benzo(a)pyrene; D003520:Cyclophosphamide; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D005978:Glutathione